NCT02292628View on ClinicalTrials.gov

Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Faecal Incontinence
Interventions
DRUG

Infusion of mesenchymal stem cells from adipose tissue

OTHER

Infusion of placebo

Trial Locations (4)

21005

H. Juan Ramón Jiménez, Huelva

28040

Fundación Jiménez Díaz, Madrid

29010

Hospital Regional U de Málaga, Málaga

41013

Hospital U Virgen del Rocio, Seville

All Listed Sponsors
collaborator

Iniciativa Andaluza en Terapias Avanzadas

OTHER

lead

Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud

OTHER

NCT02292628 - Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence | Biotech Hunter | Biotech Hunter